WallStreetZenWallStreetZen

NASDAQ: DYAI
Dyadic International Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their DYAI stock forecasts and price targets.

Forecast return on equity

Is DYAI forecast to generate an efficient return?

Company
N/A
Industry
85.39%
Market
170.3%

Forecast return on assets

Is DYAI forecast to generate an efficient return on assets?

Company
N/A
Industry
29.6%

DYAI earnings per share forecast

What is DYAI's earnings per share in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$0.09
Avg 2 year Forecast
$0.01

DYAI revenue forecast

What is DYAI's revenue in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
$6.9M+80.82%
Avg 2 year Forecast
$13.4M+250.92%
Avg 3 year Forecast
$32.9M+763.51%
DYAI's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

DYAI revenue growth forecast

How is DYAI forecast to perform vs Biotechnology companies and vs the US market?

Company
100.53%
Industry
36.49%
Market
13.73%
DYAI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
DYAI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

DYAI vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
DYAI$0.74N/AN/A
SKYE$0.77N/AN/A
NEUP$4.93$7.00+41.99%Buy
NRSN$0.81$8.50+949.38%Strong Buy
TPST$1.86$11.00+491.40%Buy
View Top Biotech Stocks

Dyadic International Stock Forecast FAQ

What is DYAI's earnings growth forecast for 2026-2027?

(NASDAQ: DYAI) Dyadic International's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 15.84%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 33.32%.

Dyadic International's earnings in 2026 is -$7,291,732.On average, 4 Wall Street analysts forecast DYAI's earnings for 2026 to be -$3,345,073, with the lowest DYAI earnings forecast at -$4,285,191, and the highest DYAI earnings forecast at -$2,295,638.

In 2027, DYAI is forecast to generate $371,675 in earnings, with the lowest earnings forecast at -$5,713,589 and the highest earnings forecast at $6,886,915.

If you're new to stock investing, here's how to buy Dyadic International stock.

What is DYAI's revenue growth forecast for 2026-2028?

(NASDAQ: DYAI) Dyadic International's forecast annual revenue growth rate of 100.53% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 36.49%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.73%.

Dyadic International's revenue in 2026 is $3,807,729.On average, 4 Wall Street analysts forecast DYAI's revenue for 2026 to be $250,880,470, with the lowest DYAI revenue forecast at $178,549,645, and the highest DYAI revenue forecast at $325,215,424. On average, 4 Wall Street analysts forecast DYAI's revenue for 2027 to be $486,893,949, with the lowest DYAI revenue forecast at $249,969,503, and the highest DYAI revenue forecast at $734,604,252.

In 2028, DYAI is forecast to generate $1,198,104,555 in revenue, with the lowest revenue forecast at $702,356,000 and the highest revenue forecast at $1,714,222,344.

What is DYAI's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: DYAI) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 29.6%.

What is DYAI's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: DYAI) Dyadic International's current Earnings Per Share (EPS) is -$0.23. On average, analysts forecast that DYAI's EPS will be -$0.09 for 2026, with the lowest EPS forecast at -$0.12, and the highest EPS forecast at -$0.06. In 2027, DYAI's EPS is forecast to hit $0.01 (min: -$0.16, max: $0.19).

What is DYAI's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: DYAI) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.